Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study

BACKGROUND: Few studies have prospectively reported outcomes in patients with pulmonary arterial hypertension (PAH) treated with epoprostenol in the modern-day era of oral therapy and combination treatments. The Registry to Prospectively Describe Use of Epoprostenol for Injection (Veletri, prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://www.ncbi.nlm.nih.gov/pubmed/25320967
http://dx.doi.org/10.1378/chest.14-1004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://www.ncbi.nlm.nih.gov/pubmed/25320967
http://dx.doi.org/10.1378/chest.14-1004

Ejemplares similares